血小板数量增加与女性的性别和喘严重程度有关
Neha Solanki1,2, Battoul Fakhry3, Amy Attaway1,2
1Integrated Hospital Care Institute, Cleveland Clinic, Cleveland, Ohio.
The journal of allergy and clinical immunology. Global
|September 2, 2025
概括
患有喘的女性血小板数量较高,这与喘严重程度的增加有关. 血小板计数可以作为喘的生物标志物,对炎症有性别特异性的影响.
科学领域:
- 肺部医学
- 血液学
- 免疫学
背景情况:
- 喘在整个生命中表现出基于性别的显著差异.
- 血小板激活与耐固醇喘有关.
- 性别差异在喘患病率和严重程度上已得到充分证实.
研究的目的:
- 调查女性血小板数量较高与男性相比喘患病率和严重性增加的假设.
- 探索血小板数量与喘严重程度之间的关系.
主要方法:
- 对英国生物库参与者的基线数据进行了横截面分析.
- 双项多变量逻辑回归调整为共变量,包括年龄,BMI,性别,种族,吸烟状态,C反应蛋白和绝对乙酸和中性酸细胞数量.
- 对男女血小板数量进行比较,并与喘严重程度和炎症标志物相关联.
主要成果:
- 在喘患者和非喘患者中,女性的血小板数量较高.
- 患有喘的女性的血小板数量中位数明显高于患有喘的男性 (30 × 10^3/μL).
- 喘患者血小板数量增加与喘严重程度和C反应性蛋白水平升高,绝对乙酸细胞数量和绝对中性细胞数量相关.
结论:
- 血小板数量与男性和女性的喘和炎症有关,这表明它可能是喘严重性的生物标志物.
- 在喘中,血小板数量的性别差异需要进一步研究.
- 未来的研究应该通过机理学研究探索性激素,血小板激活和喘严重程度之间的相互作用.
相关概念视频
Asthma-I: Introduction
2.8K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
2.8K
Asthma-II: Pathophysiology and Classification
2.8K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.8K
Asthma: Pathogenesis and Management
576
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
576
Asthma-III: Symptoms and Complications
2.6K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.6K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
644
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
644
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K


